Senator Tommy Tuberville (R-Ala.) could have his eye on sectors that could outperform in 2026 with a new financial disclosure showing the sale of several Magnificent 7 stocks and the purchase of multiple sector ETFs.
Here's a look at the transactions.
Senator Tommy Tuberville Trades Magnificent 7 Stocks For ETFs
While some members of Congress are loading up on Magnificent 7 stocks for 2026, Tuberville has sold out of his positions in three of the world’s largest companies, according to the Benzinga Government Trades page.
Here were Tuberville's latest sales:
- Dec. 17, 2025: Sold $50,000 to $100,000 in Apple Inc (NASDAQ:AAPL) stock
- Dec. 17, 2025: Sold $1,000 to $15,000 in Alphabet Inc (NASDAQ:GOOGL) stock
Here were Tuberville's purchases:
- Dec. 17, 2025: Bought $15,000 to $50,000 in State Street Consumer Staples Select Sector SPDR ETF (NYSE:XLP)
- Dec. 17, 2025: Bought $15,000 to $50,000 in State Street Utilities Select SPDR ETF (NYSE:XLU)
- Dec. 17, 2025: Bought $15,000 to $50,000 in State Street Health Care Select SPDR ETF (NYSE:XLV)
The latest transaction adds to Tuberville's recent selling of Magnificent 7 stocks. The senator also sold Apple and Alphabet shares in October and April and Apple shares in January. Shares of another Magnificent 7 stock were sold in October, April and January with the senator selling off shares of Microsoft Corporation (NASDAQ:MSFT).
Alphabet was the top-gaining Magnificent 7 stock in 2025 with shares up 65.2%. Apple and Microsoft stock were up 11.5% and 15.5%, respectively, with both companies trailing the S&P 500.
Tuberville's new bets on the sector ETFs could indicate that he sees strength coming in consumer staples, utilities and health care. These three ETFs are up 6.7%, 10.0%, and 10.9%, respectively, over the last 52 weeks.
The senator is a member of several committees, including the Senate Committee on Health, Education, Labor and Pensions. Tuberville has previously bought shares of consumer staples and utility stocks, while the health care sector purchase could highlight a potential bullish bet.
Tommy Tuberville's Trading Activity
Past trades made by Tuberville have attracted attention due to their relationship to his congressional committees and the timing of the trades.
In 2024, Tuberville was actively buying and selling options related to multiple technology stocks.
Tuberville also previously bought shares of small biotech Humacyte Inc. The trades drew attention, given the small-cap nature of the company and the fact that Tuberville serves on the Senate Armed Services Committee. The company previously tested its tech in Ukraine, treating combat injuries.
Tuberville has been flagged for unusual stock trading in the past and remained one of the most active members of Congress buying and selling stocks and options. Past trades, such as buying Intel stock before the CHIPS Act and buying shares of ChannelAdvisor days before it announced an acquisition, have drawn attention to the senator’s trading history.
A previous filing showed Tuberville buying stock in regional bank Southern States Bancshares Inc. The CEO of the company was a donor to Tuberville's Senate campaign.
A previous report from Business Insider said Tuberville was late disclosing around 130 stock trades from January to May 2021.
A report from the New York Times previously highlighted Tuberville bought or sold stock and options in 17 companies that had business in front of Senate committees on which he served.
© Jack Gruber, Jack Gruber / USA TODAY NETWORK via Imagn Images
